Evolus (EOLS) EBT Margin (2019 - 2026)

Evolus (EOLS) reported EBT Margin of 14.24% for Q1 2026, up 1322.0% on a YoY basis from 1.0% in Q1 2025, and down 2597.63% quarter-over-quarter from 0.57% in Q4 2025.

Evolus (EOLS) EBT Margin (2019 - 2026) Analysis & Trends

Evolus has reported EBT Margin for 8 years, with the latest figure at 14.24% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin rose 1322.0% year-over-year to 14.24%; the trailing twelve-month figure through Mar 2026 stood at 14.1% (up 605.0% YoY), and the FY2025 full-year result was 17.15%, up 154.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 14.24%, down from 0.57% in the prior quarter.
  • The five-year high for EBT Margin was 0.57% in Q4 2025, with the low at 63.08% in Q2 2022.
  • Historically, EBT Margin has averaged 29.18% across 5 years, with a median of 27.47% in 2025.
  • Annual changes were most pronounced in 2022 — EBT Margin tumbled 10401 bps — and 2023, when it soared 2637 bps.
  • Evolus' EBT Margin stood at 30.03% in 2022, then surged by 36 bps to 19.22% in 2023, then jumped by 58 bps to 8.04% in 2024, then surged by 107 bps to 0.57% in 2025, then plunged by 2598 bps to 14.24% in 2026.
  • The last three EBT Margin figures came in at 14.24% (Q1 2026), 0.57% (Q4 2025), and 22.58% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 10.97%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 33.51%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 40.73%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 25.87%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 30.30%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.35%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -156.77%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 41.45%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -16.70%
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn -14.24%

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.24%
Dec 31, 2025 0.57%
Sep 30, 2025 -22.58%
Jun 30, 2025 -24.63%
Mar 31, 2025 -27.47%
Dec 31, 2024 -8.04%
Sep 30, 2024 -31.16%
Jun 30, 2024 -16.90%
Mar 31, 2024 -22.01%
Dec 31, 2023 -19.22%
Sep 30, 2023 -33.79%
Jun 30, 2023 -36.71%
Mar 31, 2023 -35.40%
Dec 31, 2022 -30.03%
Sep 30, 2022 -59.78%
Jun 30, 2022 -63.08%
Mar 31, 2022 -51.62%
Dec 31, 2021 -52.42%
Sep 30, 2021 -72.80%
Jun 30, 2021 -59.74%